Company: LIMN
Filing Date: 2025-01-16
Form Type: POS AM
Source: 0001104659-25-003835
Chunk: 493

Company: Liminatus Pharma, Inc.
Filing Date: 2025-01-16
Form: POS AM
Chunk 493
---
 | December 31,2023 
 ​                | ​ |        ​ | ​ | ​ 
 ​ | ​ 
 ​ | December 31,2022 
 ​                | ​ |        ​ | ​ | ​ 
 ​ |
|:------------------------------|:--|:--|:-----------------|:--|---------:|:--|:--|:--|:-----------------|:--|---------:|:--|:--|
| Current                       | ​ | ​ | ​                | $ |   33,987 | ​ | ​ | ​ | ​                | $ |  539,823 | ​ | ​ |
| Deferred                      | ​ | ​ | ​                | ​ | -411,035 | ​ | ​ | ​ | ​                | ​ | -287,359 | ​ | ​ |
| State                         | ​ | ​ | ​                | ​ |        ​ | ​ | ​ | ​ | ​                | ​ |        ​ | ​ | ​ |
| Current                       | ​ | ​ | ​                | ​ |        — | ​ | ​ | ​ | ​                | ​ |        — | ​ | ​ |
| Deferred                      | ​ | ​ | ​                | ​ |        — | ​ | ​ | ​ | ​                | ​ |        — | ​ | ​ |
| Change in valuation allowance | ​ | ​ | ​                | ​ |  411,035 | ​ | ​ | ​ | ​                | ​ |  287,359 | ​ | ​ |
| Income tax provision          | ​ | ​ | ​                | $ |   33,987 | ​ | ​ | ​ | ​                | $ |  539,823 | ​ | ​ |

In assessing the realization of the deferred tax assets, management considers whether it is more likely than not that some portion of all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which temporary differences representing net future deductible amounts become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. After consideration of all of the information available, management believes that significant uncertainty exists with respect to future realization of the deferred tax assets and has therefore established a full valuation allowance. For the years ended December 31, 2023 and 2022, the change in the valuation allowance was $411,035 and $287,359, respectively